Health Catalyst
HCAT
180 hedge funds and large institutions have $766M invested in Health Catalyst in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 40 reducing their positions, and 41 closing their positions.
93% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 41
2.41% less ownership
Funds ownership: 99.85% → 97.45% (-2.4%)
3% less funds holding
Funds holding: 185 → 180 (-5)
45% less capital invested
Capital invested by funds: $1.39B → $766M (-$625M)
88% less call options, than puts
Call options by funds: $174K | Put options by funds: $1.39M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$19.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.2M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.1M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.8M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$48.1M |
| 3 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
-$31.9M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$21.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$16.4M |
HCAT Hedge Fund Activity: Q2 2022 in Review
180 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q2 2022, worth a combined $766M — down 45% from $1.39B a quarter earlier.
Sellers outnumbered buyers: 41 funds closed out of HCAT and 38 opened new positions — a net loss of 3 holders — while 40 trimmed existing stakes and 77 added.
The largest buyer was Goldman Sachs, adding an estimated $19.8M. The largest seller was Fidelity Investments, cutting an estimated $48.8M.
- 180 institutional investors held Health Catalyst (HCAT) as of Q2 2022, down from 185 in Q1 2022.
- Funds reported $766M of Health Catalyst stock for Q2 2022, down 45% quarter-over-quarter.
- 38 funds opened new Health Catalyst positions in Q2 2022 and 41 closed out, a net change of -3 holders.
- The largest Health Catalyst buyer in Q2 2022 was Goldman Sachs, an estimated $19.8M added.
- The largest Health Catalyst seller in Q2 2022 was Fidelity Investments, an estimated $48.8M sold.
Based on aggregated 13F filings for Q2 2022.